Cas:216854-55-6 S-(1,2-diformylpyrazolidin-4-yl) ethanethioate manufacturer & supplier

We serve Chemical Name:S-(1,2-diformylpyrazolidin-4-yl) ethanethioate CAS:216854-55-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

S-(1,2-diformylpyrazolidin-4-yl) ethanethioate

Chemical Name:S-(1,2-diformylpyrazolidin-4-yl) ethanethioate
CAS.NO:216854-55-6
Synonyms:4-(acetylthio)-1,2-diformyl pyrazolidine
Molecular Formula:C7H10N2O3S
Molecular Weight:202.23100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:82.99000
Exact Mass:202.04100
LogP:0.62770

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-(acetylthio)-1,2-diformyl pyrazolidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(acetylthio)-1,2-diformyl pyrazolidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(acetylthio)-1,2-diformyl pyrazolidine Use and application,4-(acetylthio)-1,2-diformyl pyrazolidine technical grade,usp/ep/jp grade.


Related News: Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more. S-(1,2-diformylpyrazolidin-4-yl) ethanethioate manufacturer The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. S-(1,2-diformylpyrazolidin-4-yl) ethanethioate supplier Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. S-(1,2-diformylpyrazolidin-4-yl) ethanethioate vendor The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. S-(1,2-diformylpyrazolidin-4-yl) ethanethioate factory Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.